Hosted on MSN1mon
Light-activated compound offers hope for overcoming drug resistance in cancer treatmentIn preclinical studies, when this photoreactive compound was administered to mice with drug-resistant pancreatic cancer and subsequently exposed to infrared light, the results were striking.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback